RxSight, Inc. (RXST) vs Surrozen, Inc. (SRZN)
A side-by-side comparison of RxSight, Inc. and Surrozen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RXST
RxSight, Inc.
$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SRZN
Surrozen, Inc.
$26.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RXST vs SRZN
growth of $100 · dividends reinvested · last 5yRXST -70.3% (-21.5%/yr)SRZN -80.5% (-27.9%/yr)RXST compounded faster over this window
RXST SRZN
RXST vs SRZN: by the numbers
- •SRZN is the larger company ($197M vs $192M market cap).
- •Both run net losses; RXST's is the smaller (-36.80% vs -2885.33% net margin).
Metrics side by side
Valuation
| Metric | RXST | SRZN |
|---|---|---|
| P/S ratio | 1.51 | 17.13 |
| P/B ratio | 0.73 | N/A |
Profitability
| Metric | RXST | SRZN |
|---|---|---|
| Gross margin | 77.50% | 84.56% |
| Operating margin | -43.20% | -1210.58% |
| Net margin | -36.80% | -2885.33% |
| ROE | -17.83% | N/A |
| ROIC | -20.24% | -41.61% |
Growth (annualized)
| Metric | RXST | SRZN |
|---|---|---|
| Revenue CAGR (5Y) | 48.85% | N/A |
| Total return CAGR (5Y) | -19.19% | -20.80% |
Frequently asked
- How have RXST and SRZN total returns compared?
- Over the past 5 years, RXST delivered -19.19% and SRZN delivered -20.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
RxSight ROESurrozen ROERxSight operating marginSurrozen operating marginRxSight revenue growthSurrozen revenue growthRxSight free cash flowSurrozen free cash flow
RxSight & Surrozen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.